yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q36298863-66D6507B-DD7B-42C8-BF3B-4E0B8225E6D2
Q36298863-66D6507B-DD7B-42C8-BF3B-4E0B8225E6D2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36298863-66D6507B-DD7B-42C8-BF3B-4E0B8225E6D2
Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer.
P2860
Q36298863-66D6507B-DD7B-42C8-BF3B-4E0B8225E6D2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36298863-66D6507B-DD7B-42C8-BF3B-4E0B8225E6D2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b6c1509e42a2c3da0428851df1c7b13beb59d31a
P2860
Phase I study of ARN-509, a novel antiandrogen, in the treatment of castration-resistant prostate cancer.